AUTOMATED CANCER DATA COLLECTION
AIM solutions for automated electronic data collection feature HIPAA and NIST compliant security, and include fault tolerance, and A.I. technology to achieve high filtering accuracy to minimize the risk of undue disclosure of PHI. Our E-Path system, for example, is the industry leading solution for automated real-time cancer diagnosis detection and reporting from hospitals and laboratories to cancer registries, with a sensitivity/specificity exceeding 99%.
DATA CONSOLIDATION & AUTO-ABSTRACTING
AIM's Abrevio™ is ideal for retrospective research studies, improving clinical trial uptake, trend & compliance monitoring, and for improving efficiency in cancer abstracting and reporting. The Abrevio™ clinical document processing platform links documents from various sources to patient/cases of cancer and auto-abstracts diagnostic, clinical, treatment, outcome, and other information into a centralized searchable database of annotated cases.
BIOBANK INFORMATION MANAGEMENT
Studying the molecular nature of disease requires high quality specimens from richly annotated cases of patient disease. TissueMetrix™ provides the tools to accurately describe specimens, patients, and disease properties, while tracking specimen collection receipt, preparation, storage and chain-of-custody. TissueMetrix™ features FDA CFR 21/11 security controls to protect privacy and enforce secure access in a multi-study, multi-site environments.
AIM’s software solutions contain elements of artificial intelligence (AI) technology to improve the accuracy and efficiency of data processing as well as streamline workflows. Our team of knowledgeable engineers, programmers and subject matter experts develop and train AI components so that our customers don’t need to—the AI works to specified levels of performance out-of-the-box. And we monitor, evaluate, and improve performance on an on-going basis. The role of AI in our applications is not to replace the work of people, but to greatly enhance their capabilities and drive achievement.
We use TissueMetrix to manage the data associated with tissue samples collected for research.
Dr. David Malkin, Director, Cancer Genetics Program | Hospital for Sick Children, Toronto, ON
TissueMetrix manages the data associated with the samples collected. The system has been deployed in both of our centers, utilizing a VPN connection
Dr. Brenda Banwell, Director of Paediatric Multiple Sclerosis (MS) Clinic & Professor of Paediatrics at The Hospital for Sick Children | Montreal, QC & Toronto, ON
Tissue samples and associated clinical data are now secure and easily searchable by authorized staff using TissueMetrix’s user-defined queries.
Xandi Hamilton, CGRL Coordinator | North Carolina State University, College of Veterinary Medicine
The TissueMetrix platform provides us with the rigor we require, while enabling us to maintain the flexibility to address project-specific data needs.
Dr. Kenneth Evans, President & CEO | The Ontario Cancer Biomarker Network, Toronto, ON
Silos no longer... now with TissueMetrix, everything is in one spot...
Julie Buckmeier, Research Administrator | The University of Arizona Cancer Center